IKS Health announced its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2025. The company reported consolidated total income of ₹7,847.46 million for the quarter. The Board of Directors approved these results on October 30, 2025.
Financial Performance Overview
IKS Health has released its unaudited financial results for Q2 2026, showcasing the following consolidated highlights:
Key Financial Figures
Total Income: Total income reached ₹7,847.46 million for the quarter ended September 30, 2025.
Profit Before Tax: The company’s profit before tax stood at ₹2,277.08 million.
Net Profit: IKS Health reported a profit for the period of ₹1,807.19 million.
Segment Reporting
The company operates primarily within the care enablement platform, offering technology-enabled solutions for healthcare providers.
Subsidiaries and Associates
The consolidated financial results encompass IKS Health’s subsidiaries and its share of profit/loss from associates, including IKS WWMG MSO LLC.
Equity and Share Capital
The paid-up equity share capital remains at ₹170.44 million.
Source: BSE
